A detailed history of Platform Technology Partners transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Platform Technology Partners holds 4,560 shares of VKTX stock, worth $313,956. This represents 0.09% of its overall portfolio holdings.

Number of Shares
4,560
Holding current value
$313,956
% of portfolio
0.09%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$49.84 - $70.47 $227,270 - $321,343
4,560 New
4,560 $288,000

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $5.28B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Platform Technology Partners Portfolio

Follow Platform Technology Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Platform Technology Partners, based on Form 13F filings with the SEC.

News

Stay updated on Platform Technology Partners with notifications on news.